Skip to main content
Top
Published in: Lung 3/2009

01-06-2009

Impaired Sleep Reduces Quality of Life in Chronic Obstructive Pulmonary Disease

Authors: Deuzilane Muniz Nunes, Rosa Maria Salani Mota, Osvaldo Leite de Pontes Neto, Eanes Delgado Barros Pereira, Veralice Meireles Sales de Bruin, Pedro Felipe Carvalhedo de Bruin

Published in: Lung | Issue 3/2009

Login to get access

Abstract

Disturbed sleep is reportedly common in chronic obstructive pulmonary disease (COPD), but the impact of quality of sleep on health-related quality of life (HRQL) has not been previously investigated in these individuals. The purpose of this study was to assess the impact of quality of sleep on HRQL in patients with COPD. In 30 clinically stable patients with moderate to very severe COPD, we evaluated subjective sleep quality using the Pittsburgh Sleep Quality Index (PSQI) and HRQL using the Saint George’s Respiratory Questionnaire. Additionally, lung function was assessed by spirometry, severity of dyspnea by the Modified Medical Research Council scale, and functional exercise capacity by the Six-Minute Walk Test. Twenty-one (70%) patients showed poor quality of sleep (PSQI > 5). HRQL was significantly correlated with quality of sleep (P = 0.02), post-bronchodilator FEV1 (P = 0.04), and severity of dyspnea (P < 0.01). Multiple regression analysis showed that quality of sleep was the best predictor of quality of life in our subjects. Our data suggest that quality of sleep is major determinant of HRQL in COPD. Increased efforts to diagnose and treat sleep problems, including measures to improve factors that adversely affect sleep should receive great attention in the daily management of these patients.
Literature
8.
go back to reference Santos CEVG, Viegas CAA (2003) Sleep pattern in patients with chronic obstructive pulmonary disease and correlation among gasometric, spirometric, and polysomnographic variables. J Pneumol 29:69–74 Santos CEVG, Viegas CAA (2003) Sleep pattern in patients with chronic obstructive pulmonary disease and correlation among gasometric, spirometric, and polysomnographic variables. J Pneumol 29:69–74
9.
go back to reference Fleetham J, West P, Mezon B, Conway W, Roth T, Kryger MH (1982) Sleep, arousals and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am Rev Respir Dis 126:429–433PubMed Fleetham J, West P, Mezon B, Conway W, Roth T, Kryger MH (1982) Sleep, arousals and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am Rev Respir Dis 126:429–433PubMed
10.
go back to reference Stege G, Vos PJE, Elshout FJJV, Dekhuijzen PNR, Van de Ven MJT, Heijdra YF (2008) Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med 102:801–814PubMedCrossRef Stege G, Vos PJE, Elshout FJJV, Dekhuijzen PNR, Van de Ven MJT, Heijdra YF (2008) Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med 102:801–814PubMedCrossRef
15.
go back to reference Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G (2004) Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the quality of sleep in allergic rhinitis study. Ann Allergy Asthma Immunol 92:255–261PubMedCrossRef Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G (2004) Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the quality of sleep in allergic rhinitis study. Ann Allergy Asthma Immunol 92:255–261PubMedCrossRef
17.
go back to reference Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555. doi:10.1164/rccm.200703-456SO PubMedCrossRef Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555. doi:10.​1164/​rccm.​200703-456SO PubMedCrossRef
20.
go back to reference Sousa TC, Jardim JR, Jones P (2000) Validation of the Saint George’s respiratory questionnaire in patients with chronic obstructive pulmonary disease. J Pneumol 26:119–125 Sousa TC, Jardim JR, Jones P (2000) Validation of the Saint George’s respiratory questionnaire in patients with chronic obstructive pulmonary disease. J Pneumol 26:119–125
21.
go back to reference American Thoracic Society (1995) Standardisation of spirometry 1994 update. Am J Respir Crit Care Med 152:1107–1136 American Thoracic Society (1995) Standardisation of spirometry 1994 update. Am J Respir Crit Care Med 152:1107–1136
22.
go back to reference Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B (1983) Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 127:725–734PubMed Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B (1983) Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 127:725–734PubMed
23.
go back to reference Brooks SM (1982) Surveillance for respiratory hazards. ATS News 8:12–16 Brooks SM (1982) Surveillance for respiratory hazards. ATS News 8:12–16
24.
go back to reference American Thoracic Society (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117 American Thoracic Society (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117
25.
go back to reference Norusis MJ (2006) SPSS for windows: base system user’s guide, release 15.0 Norusis MJ (2006) SPSS for windows: base system user’s guide, release 15.0
27.
go back to reference Lewis CA, Ferguson W, Eaton T, Zeng I, Kolbe J (2009) Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax 64:133–138PubMedCrossRef Lewis CA, Ferguson W, Eaton T, Zeng I, Kolbe J (2009) Isolated nocturnal desaturation in COPD: prevalence and impact on quality of life and sleep. Thorax 64:133–138PubMedCrossRef
28.
go back to reference Van Manen JG, Bindels PJE, Dekker FW, Ijzermans CJ, Bottema BJAM, Van Der Zee JS, Schadé E (2001) Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir Med 95:496–504. doi:10.1053/rmed.2001.1077 PubMedCrossRef Van Manen JG, Bindels PJE, Dekker FW, Ijzermans CJ, Bottema BJAM, Van Der Zee JS, Schadé E (2001) Added value of co-morbidity in predicting health-related quality of life in COPD patients. Respir Med 95:496–504. doi:10.​1053/​rmed.​2001.​1077 PubMedCrossRef
32.
go back to reference Medeiros CAM, Bruin PFC, Lopes LA, Magalhães MC, Seabra ML, Bruin VMS (2007) Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease: a randomized, double blind, placebo-controlled study. J Neurol 254:459–464. doi:10.1007/s00415-006-0390-x PubMedCrossRef Medeiros CAM, Bruin PFC, Lopes LA, Magalhães MC, Seabra ML, Bruin VMS (2007) Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson’s disease: a randomized, double blind, placebo-controlled study. J Neurol 254:459–464. doi:10.​1007/​s00415-006-0390-x PubMedCrossRef
33.
go back to reference Vgontzas AN, Bixler EO, Kales A, Manfredi RL, Tyson K (1994) Validity and clinical utility of sleep laboratory criteria for insomnia. Int J Neurosci 77:11–21PubMedCrossRef Vgontzas AN, Bixler EO, Kales A, Manfredi RL, Tyson K (1994) Validity and clinical utility of sleep laboratory criteria for insomnia. Int J Neurosci 77:11–21PubMedCrossRef
34.
go back to reference McNicholas WT (2006) Sleep in chronic obstructive pulmonary disease. Eur Respir Mon 38:325–336 McNicholas WT (2006) Sleep in chronic obstructive pulmonary disease. Eur Respir Mon 38:325–336
36.
go back to reference Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T (2000) Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 94:841–846. doi:10.1053/rmed.2000.0804 PubMedCrossRef Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T (2000) Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. Respir Med 94:841–846. doi:10.​1053/​rmed.​2000.​0804 PubMedCrossRef
37.
go back to reference Stahl E, Lindberg A, Jansson S, Rönmark E, Svensson K, Andersson F, Löfdahl C, Lundbäck B (2005) Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 3:56. doi:10.1186/1477-7525-3-56 PubMedCrossRef Stahl E, Lindberg A, Jansson S, Rönmark E, Svensson K, Andersson F, Löfdahl C, Lundbäck B (2005) Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes 3:56. doi:10.​1186/​1477-7525-3-56 PubMedCrossRef
38.
go back to reference Miravitlles M, Ferrer M, Pont A, Viejo JL, Masa JF, Gabril R, Jiménez-Ruiz CA, Villasante C, Fernández-Fau L, Sobradillo V (2005) Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 99:985–995. doi:10.1016/j.rmed.2005.01.012 PubMedCrossRef Miravitlles M, Ferrer M, Pont A, Viejo JL, Masa JF, Gabril R, Jiménez-Ruiz CA, Villasante C, Fernández-Fau L, Sobradillo V (2005) Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers. Respir Med 99:985–995. doi:10.​1016/​j.​rmed.​2005.​01.​012 PubMedCrossRef
Metadata
Title
Impaired Sleep Reduces Quality of Life in Chronic Obstructive Pulmonary Disease
Authors
Deuzilane Muniz Nunes
Rosa Maria Salani Mota
Osvaldo Leite de Pontes Neto
Eanes Delgado Barros Pereira
Veralice Meireles Sales de Bruin
Pedro Felipe Carvalhedo de Bruin
Publication date
01-06-2009
Publisher
Springer-Verlag
Published in
Lung / Issue 3/2009
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-009-9147-5

Other articles of this Issue 3/2009

Lung 3/2009 Go to the issue